Assessing Psychological Distress in Cancer Patients: Validation of a Self-Administered Questionnaire

Abstract

Background: screening for psychological distress in cancer patients is important, considering the high prevalence of psychiatric disorders responsive to treatment. The aim of this study is to test the psychometric properties of the Psychological Distress Inventory (PDI), a 13-item self-administered questionnaire developed to measure psychological distress in cancer patients. Patients and Methods: The PDI was tested in three samples of 434 cancer patients. In the first sample (n = 102) it was administered with the State Trait Anxiety Inventory (STAI) and with the Eysenck Personality Questionnaire (EPQ). Its validity as a screening method for psychiatric disorders was evaluated through a clinical interview in the second sample (n = 107). The third sample (n = 225) provided information on the ability of the PDI to discriminate among patients in different clinical phases of disease and allowed an estimate of the prevalence of psychiatric disorders in these groups of patients. Results: A 0.88 a coefficient was obtained in the whole study sample. The correlations with the STAI scales were > 0.70. A positive correlation with neuroticism (r = 0.59) and a negative correlation with extroversion (r = ––0.34) was observed. In the second sample, 67 patients (62.6%) received a psychiatric diagnosis according to the ICD-X criteria. The mean PDI scores were significantly lower for the 40 patients with no psychiatric diagnosis (mean 24.5) as compared with the 49 patients with adjustment disorders (mean 36.4) and with the 12 patients with depressive disorders (mean 40.8). The area under curve, estimated through a Receiver-Operating Characteristics analysis, was 0.88. A cut-off of 29 was associated with a 75% sensitivity and a 85% specificity. In the third sample, the lowest PDI scores were in patients with no evidence of disease (mean 24.7, 95% CL 23.0–26.4) as compared to patients undergoing antineoplastic treatment (mean 30.9, 95% CL 28.9–32.9) and to patients under palliative therapy (mean 36.0, 95% CL 34.0–37.9). The estimated prevalence of patients with psychiatric disorders in these three groups were respectively 5.0, 56.6 and 98.8%. Conclusions: Our results suggest that the PDI is a reliable and valid tool for measuring psychological distress in cancer patients and to detect psychiatric disorders through a screening procedure.

Health Related Quality of Life Assessment of Cancer Patients during Chemotherapy / Radiotherapy among Saudi Population

“…Poor HRQoL was also noted in pts with advanced stage and terminal disease (Table 5). Physical problems and psychiatric disorders are noted higher in terminally ill cancer pts [9] . Generalized weakness and fatigue can be extremely debilitating and may have a severe negative impact on quality of life.…”

Sensitivity and Specificity of the Distress Thermometer in Screening for Distress in Long-Term Nasopharyngeal Cancer Survivors

“…Various screening tools have been developed to quickly identify people who may be psychologically distressed 18,20,21 . The Distress Thermometer (dt) is recommended by the nccn 18 .…”

Psychological Distress in Cancer Patients Attending the European Institute of Oncology in Milan

“…interviews vs. self-assessment) or diagnostic criteria (e.g. cutoff scores for determining pathological cases) [4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14]. …”